Finding Description
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. Resident 30's record was reviewed on 1/5/23 at 12:59 p.m. The record indicated diagnoses that included, but were not limited to, repeated falls, altered mental status, high blood pressure, anxiety, depression, and vascular dementia.
An Annual Minimum Data Set (MDS) assessment, dated 4/22/22, indicated Resident 30 was cognitively intact, speech was clear, had no moods or behaviors, did not receive antipsychotic medications.
A Quarterly MDS assessment, dated 11/28/22, indicated Resident 30 was cognitively intact, speech was clear, had moods of feeling down, depressed or hopeless, trouble falling or staying asleep, or sleeping too much, feeling tired or having little energy, poor appetite or overeating, had no behaviors, received an antipsychotic routinely for seven out of seven days of the assessment, a gradual dose reduction had not been attempted, and a gradual dose reduction has not been documented by a physician as clinically contraindicated.
A care plan, dated 6/1/22, indicated a problem of Disruptive verbally. This res is rude to her peers; makes fun of them, laughs at them, tells them what to do, etc. Diagnosis of Mood Disorder .6/15/22 Manifested by: verbal outbursts, verbal intimidation. Approach: Nurses - provide calm environment, administer medications as ordered by physician; Abilify, redirect, do not reorient or argue with [Resident 30], if need be remove her from her peers if able. Nurse Aide - Positive approach with resident, count verbal outbursts, document and report behaviors to nurse and/or social services, maintain safety of resident and other residents, and other staff, if able remove [Resident 30] from the area
Current physician's orders included an order for an antipsychotic medication - Abilify (generic name is aripiprazole) 2 milligrams by mouth every day, for mood disorder, with a start date of 5/5/22.
On 1/10/23 at 10:45 a.m., the Nurse Practitioner said Resident 30 was on Abilify and she doesn't get a report of signs and symptoms but the Director of Nursing will call and let her know what is going on. She wasn't aware that mood disorder was not an accepted diagnosis for the use of an antipsychotic.
An Informed Consent for Medication for the use of Abilify, indicated Completion of this form is voluntary. If not completed, the medication cannot be administered without a court order unless in an emergency. This consent is maintained in the client's record and is accessible to authorized users The consent was signed by the resident on 1/10/23 and the Ability had been administered since 5/5/22. The informed consent included, but was not limited to, side effects and cautions such as changes in thinking, fever, muscle stiffness, low blood pressure when standing, fall risk, weight gain, and seizure. The following was indicated on the Informed Consent for Medication: Warning: [Black Box Warning]: Increased Mortality in Elderly Patients with Dementia Related Psychosis: Elderly patients with dementia related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. Analyses of 17 placebo controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in the drug treated patients of between 1.6 to 1.7 times that seen in placebo treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug treated patients was about 4.5% compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. Aripiprazole is not approved for the treatment of patients with dementia-related psychosis.
3. Resident 4's record was reviewed on 1/04/23 at 1:20 p.m. and indicated diagnoses that included, but were not limited to, cardiac arrhythmia, age-related physical debility, repeated falls, osteoporosis, hypertension, dementia with behavior disturbance, and heart failure.
A Quarterly MDS, dated [DATE], indicated Resident 4 was severely impaired in cognitive skills for daily decision making, had no moods or behaviors, did not walk, and did not receive an antipsychotic medication.
A Significant Change MDS, dated [DATE], indicated Resident 4 was severely impaired in cognitive skills for daily decision making, had a diagnosis of non-Alzheimer's dementia, did not walk, and received an antipsychotic medication.
A care plan, dated 9/15/22, indicated a problem for Potential for adverse medication side effects related to antipsychotic use manifested by: possible side effects: lethargy, loss of appetite, involuntary movements, tremors, chewing and /or tongue movements, muscle twitching, gait changes. Approach: Nurses - Monitor for side effects q (every) shift, notify physician of symptoms. Nurse Aide - report unusual behavior, report change in physical condition, report change in appetite. [Social Services] Involve family, make referrals, referred her to psych services, discuss in the monthly behavior management meeting. Goal: No adverse affects d/t (due to) med regimen, prevent and/or minimize the side effects of the psychotropic medications. Resident will receive the lowest possible dose necessary to control symptoms.
On 1/05/23 at 9:46 a.m., Resident 4 was in bed, eyes closed.
On 1/09/23 at 10:05 a.m., Resident 4 was in bed with her eyes closed.
On 1/09/23 at 01:48 p.m., Resident 4 was up in her wheelchair in the activity room, sitting quietly with other residents, the activity aide was in the room.
Current physician's orders included an order for the antipsychotic Seroquel 25 milligrams by mouth at bedtime for dementia, with a start date of 9/8/22.
A Pharmacy review, dated 9/29/22, indicated: [Resident 4] is receiving the antipsychotic agent Seroquel but lacks an allowable diagnosis to support its use. The following are considered appropriate diagnoses/conditions: .Dementing illnesses with associated behavioral symptoms. The physician selected Agree and chose Dementia with behavioral disturbance. Signed 9/29/22 by the Nurse Practitioner.
During an interview, on 1/10/23 at 10:37 a.m., the Nurse Practitioner indicated they started Resident 4 on the Seroquel when she started to have behaviors with her dementia, they got psych involved, and she wasn't aware that a dementing illness with associated behavioral symptoms was not an accepted diagnosis for the use of an antipsychotic.
A policy for Psychoactive Medication Protocol was provided by the Interim Executive Director on 1/6/23 at 1:22 p.m. The policy included, but was not limited to, Purpose: To ensure appropriate procedures are followed and subsequent documentation is completed prior to the initiation or change of a psychoactive medication and to ensure ongoing targeted behavior tracking for comprehensive assessment and evaluation purposes. Protocol: 1. Psychoactive medications include antipsychotics, antianxiety agents, sedatives/hypnotics, antidepressants and other medications as described below .2. The Interdisciplinary Team will identify target behaviors and develop a care plan to include treatment goals and evaluation of precipitating events, if any, in the resident's environment .3. Enter the appropriate target behaviors in the appropriate [treatment administration record] folder and begin documenting every shift. Make an appropriate corresponding entry in the medical record as warranted. 5. Physician order obtained MUST include an appropriate diagnosis for medication use and the desired therapeutic goal for the medication (i.e. reduction in the frequency or severity of a targeted behavior) for any psychoactive medications
3.1-48(a)(3)
3.1-48(b)(2)
Based on observation, interview and record review the facility failed to have an indication for the use of an antipsychotic medication, failed to implement behavioral interventions, failed to monitor antipsychotic medication and failed to provide education of the risk of using an antipsychotic medication for 3 of 5 residents reviewed for unnecessary medication use (Resident 20, Resident 30 and Resident 4).
Findings include:
1.) Review of the record of Resident 20 on 1/4/22 at 1:20 p.m., indicated the resident's diagnoses included, but were not limited to, Alzheimer's disease, altered mental status, cerebral infarction, history of falling, diabetes mellitus, hypertension, dementia,, osteoarthritis and anxiety.
The CNA behavior communication form for Resident 20, dated 8/18/22, indicated the resident was being physically abusive to the staff and was hitting and kicking. There were no documented interventions attempted.
The CNA behavior communication form for Resident 20, dated 8/30/22, indicated the resident was pulling the staff's hair. The interventions were talk/listen to the resident and reassured. These interventions were successful.
The CNA behavior communication form for Resident 20, dated 8/30/22, indicated the resident was being physically abusive to staff and was scratching the staff's arm. The interventions were talk/listen to the resident and reassured. These interventions were successful.
The CNA behavior communication form for Resident 20, dated 8/31/22, indicated the resident was being physically abusive to staff and was hitting, biting, kicking and scratching. The interventions were talk/listen to the resident and reassured. These interventions were successful.
The CNA behavior communication form for Resident 20, dated 9/1//22, indicated the resident was being physically abusive to staff and was hitting, biting, yelling and scratching. The interventions were talk/listen to the resident and reassured. These interventions were successful.
The CNA behavior communication form for Resident 20, dated 9/3//22, indicated the resident was being physically abusive to staff and was hitting, pinching and kicking. The interventions were talk/listen to the resident and offered a quiet area. These interventions were unsuccessful.
The CNA behavior communication form for Resident 20, dated 9/7//22, indicated the resident was being physically abusive to staff and was pinching and digging her nails in the staff's hand. The intervention was leave the resident alone.
The CNA behavior communication form for Resident 20, dated 9/13//22, indicated the resident was being physically abusive to staff and was scratching and made the staff's hand bleed. The intervention was reassure the resident and it was successful.
The CNA behavior communication form for Resident 20, dated 9/20//22, indicated the resident was being physically abusive to staff and was hitting and pinching staff. The interventions were talk/listen to the resident and reassured. These interventions were successful. There were no further CNA behavior communication forms documented.
The nursing behavior note for Resident 20, dated 9/2/22, indicated the resident had a behavior of pinching and scratching staff. Intervention was 1:1 conversation and reassured. These interventions were successful.
The nursing behavior note for Resident 20, dated 9/3/22, indicated the resident was scratching and punching staff when they tried to get her up in the morning. The staff attempted to take her to activities and the resident scratched the staff's arm and grabbing their shirt and kicking at staff. The staff talked with resident and listened to the resident and offered a quiet area. The resident remained unchanged.
The nursing behavior note for Resident 20, dated 9/13/22, indicated the resident scratched staff hand while in the shower room. The intervention was resident left alone and reapproached.
The nursing behavior note for Resident 20, dated 10/1/22 through 10/15/22 the resident had no documented behavior.
The nursing behavior note for Resident 20, dated 10/16/22, indicated the resident was pinching scratching and spitting at staff. The intervention was 1:1 and talking. The behavior remained unchanged.
The nursing behavior note for Resident 20, dated 10/19/22, indicated the resident was kicking and hitting staff. The intervention was reassured resident. The behavior remained unchanged.
The nursing behavior note for Resident 20, dated 10/20/22 through 11/4/22, the resident had no behaviors.
The nursing behavior note for Resident 20, dated 11/5/22, indicated the resident was kicking and hitting staff. The interventions were reassured the resident and talked with her and walked away. The intervention was successful.
The nursing behavior note for Resident 20, dated 11/6/22 through 11/17/22, the resident had no documented behaviors.
The nursing behavior note for Resident 20, dated 11/18/22, indicated the resident was yelling and crying very loudly in the hallway before dinner. Staff attempted to redirect the resident but this did not work. The resident went into the dining room and continued to yell at others and crying. The resident threw a small vase and broke it. Staff attempted to assist the resident with eating but was unsuccessful. The resident continued to yell at others and crying while making her way out of the dining room. The resident attempted to hit, grab and bite staff. The staff took the resident to her room and once in front of her bed the resident mostly stopped her behaviors. The stated she wanted to go to bed and staff assisted her to bed and covered her up. The resident cried for a couple more minutes, but then completely calmed down and went to sleep. The facility would review the resident's medications and complete a pain assessment, the resident does have dementia.
The physician order for Resident 20, dated 11/22/22, indicated the resident was ordered seroquel (antipsychotic medication) 25 milligrams (mg) at night for dementia with behaviors.
During an observation on 1/4/23 at 2:12 p.m., Resident 20 was laying in bed with her eyes closed.
During an observation on 1/5/23 at 1:46 p.m., Resident 20 was laying in bed with her eyes closed.
During an interview with the Administrator on 1/5/23 at 2:01 p.m., the facility had not been monitoring for side effects of the seroquel for Resident 20, but they would be now. The resident had not seen psychiatric services.
During an observation on 1/6/23 at 11:00 a.m., Resident 20 was laying in bed. CNA 1 asked the resident if she was ready to get up and the resident shook her head no and pointed to the door for staff to leave. CNA 2 was standing there and when queried if the facility attempted different care givers to see if the resident would get up, CNA 2 indicated yes they did. CNA 2 did not attempt to see if the resident would get up for him and no other interventions were attempted.
During an observation on 1/9/23 at 2:16 p.m., Resident 20 was laying in bed with her eyes closed.
During an interview with the Administrator on 1/10/23 at 10:14 a.m., indicated the facility had not provided Resident 20's family education on the risk of seroquel and the education would be mailed to them today. The Administrator provided a copy the education that would be mailed to the resident's family.
During an interview with Resident 20's Nurse Practitioner (NP) on 1/10/23 at 10:36 a.m., indicated the rationale behind why the medication of an antipsychotic was being used to treat Resident 20's dementia, the NP indicated the resident was combative with staff and the facility ruled out infection and started her on seroquel. When queried if the NP had been aware that the non pharmalogical interventions staff were using for Resident 20's behaviors were mostly successful, the NP indicated it was not reported to her that the non pharmalogical interventions had been successful for her behaviors.
The informed consent for the medication seroquel for Resident 20's family dated 1/10/23, indicated warning: [Black Box Warning] Increased mortality in elderly patents with dementia related psychosis: Elderly patients with dementia related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. Although the causes of death varied, most of the deaths appeared to be either cardiovascular (e.g. heart failure, sudden death) or infectious (e.g. pneumonia) in nature. This drug is not approved for the treatment of patients with dementia-related psychosis.